tiprankstipranks
Trending News
More News >

Recce Pharmaceuticals Director Increases Shareholding

Story Highlights
Recce Pharmaceuticals Director Increases Shareholding

Confident Investing Starts Here:

Recce Pharmaceuticals Ltd. ( (AU:RCE) ) has provided an update.

Recce Pharmaceuticals Ltd announced a change in the director’s interest, with Dr. John Prendergast acquiring 51,136 fully paid ordinary shares through participation in the company’s pro-rata non-renounceable entitlement offer. This acquisition reflects an increase in Dr. Prendergast’s holdings, potentially signaling confidence in the company’s strategic direction and financial health, which may positively influence stakeholder perception and market positioning.

More about Recce Pharmaceuticals Ltd.

Recce Pharmaceuticals Ltd is a company in the pharmaceutical industry, focusing on the development and commercialization of synthetic anti-infectives aimed at addressing antibiotic-resistant superbugs and emerging viral pathogens.

Average Trading Volume: 217,174

Technical Sentiment Signal: Sell

Current Market Cap: A$82.51M

See more insights into RCE stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App